99 results
Page 2 of 5
6-K
EX-99.1
0h11qptw6dtou03
27 Oct 23
XORTX Announces Results of Special Meeting of Shareholders
6:05pm
6-K
EX-99.1
9heqklgicd 18u12l
12 Oct 23
XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
7:41am
6-K
EX-99.2
dv2i1tbrqudlpx4x
4 Oct 23
Notice of Special Meeting of Shareholders
7:00am
6-K
EX-99.1
uif8v6fw963bwv
7 Sep 23
XORTX Joins the Kidney Foundation and Kidney March
8:23am
6-K
EX-99.1
r1g 0jeed
29 Aug 23
XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
7:00am
424B3
hhxs64rtjhcf2m7ieusy
25 Aug 23
Prospectus supplement
6:00am
424B3
kuznhiuk
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.2
5w7ehtpikwnes
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
424B3
ccfazy2 i9u
14 Aug 23
Prospectus supplement
4:42pm
424B3
siavs 07n9c84
14 Aug 23
Prospectus supplement
4:40pm
POS AM
5sl e3uoc
4 Aug 23
Prospectus update (post-effective amendment)
4:08pm
POS AM
EX-10.26
y0w4g4cx61gw
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
POS AM
0xpibwm3te91yf
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.2
xwqlb6zmrtkde
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.2
21mito5
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am